{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T13:12:12Z","timestamp":1723036332659},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Science and Technology","doi-asserted-by":"publisher","award":["24592510","15K1079)"],"award-info":[{"award-number":["24592510","15K1079)"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Foundation of Osaka Cancer Research"},{"name":"The Ichiro Kanehara Foundation of the Promotion of Medical Science and Medical Care"},{"name":"The Foundation for the Promotion of Cancer Research"},{"name":"The Kanzawa Medical Research Foundation"},{"name":"The Shinshu Medical Foundation"},{"name":"The Takeda Foundation for Medical Science"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bbrc.2015.06.046","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T10:20:08Z","timestamp":1434190808000},"page":"982-987","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Expression of CAVEOLIN 1 in uterine mesenchymal tumors: No relationship between malignancy and CAVEOLIN 1 expression"],"prefix":"10.1016","volume":"463","author":[{"given":"Takuma","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanri","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.06.046_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/geno.1998.5723","article-title":"Human caveolin-1 and caveolin-2 are closely linked genes colocalized with WI-5336 in a region of 7q31 frequently deleted in tumors","volume":"56","author":"Fra","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.bbrc.2015.06.046_bib2","doi-asserted-by":"crossref","first-page":"15693","DOI":"10.1074\/jbc.270.26.15693","article-title":"Evidence for a regulated interaction between heterotrimeric G proteins and caveolin","volume":"270","author":"Li","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.06.046_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jcmm.12030","article-title":"Caveolin-1 as a promoter of tumour spreading: when, how, where and why","volume":"17","author":"Senetta","year":"2013","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.bbrc.2015.06.046_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.4217","article-title":"Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression","volume":"231","author":"Ayala","year":"2013","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.bbrc.2015.06.046_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00004347-199901000-00004","article-title":"Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas","volume":"18","author":"Zhai","year":"1999","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.bbrc.2015.06.046_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/srep00180","article-title":"Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy","volume":"1","author":"Hayashi","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2015.06.046_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1636.17918","article-title":"Potential diagnostic biomarkers: LMP2\/\u03b21i and Cyclin B1 differential expression in human uterine mesenchymal tumors","volume":"100","author":"Hayashi","year":"2014","journal-title":"Tumori"},{"key":"10.1016\/j.bbrc.2015.06.046_bib8","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/sj.bjc.6601359","article-title":"Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma","volume":"89","author":"Campbell","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.046_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ijc.28001","article-title":"Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis","volume":"133","author":"Basu Roy","year":"2013","journal-title":"Intl. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.046_bib10","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1128\/MCB.23.24.9389-9404.2003","article-title":"Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine\/threonine protein phosphatases PP1 and PP2A","volume":"23","author":"Li","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2015.06.046_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/gyno.2001.6156","article-title":"Caveolin-1 expression in advanced- stage ovarian carcinoma: a clinicopathologic study","volume":"81","author":"Davidson","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.046_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.06.007","article-title":"Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle","author":"Zhou","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbrc.2015.06.046_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/09513590701690274","article-title":"Expression of sex hormone binding globulin, oxytocin receptor, caveolin-1 and p21 in leiomyoma","volume":"24","author":"Sendemir","year":"2008","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.bbrc.2015.06.046_bib14","first-page":"499","volume":"vol. 4","author":"Kurma","year":"2001"},{"key":"10.1016\/j.bbrc.2015.06.046_bib15","doi-asserted-by":"crossref","first-page":"30028","DOI":"10.1074\/jbc.M402236200","article-title":"Transcription of the Caveolin-1 Gene Is differentially regulated in lung type I epithelial and endothelial cell lines: a role for ets proteins in epithelial cell expression","volume":"279","author":"Kathuria","year":"2004","journal-title":"J.Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.06.046_bib16","first-page":"24","article-title":"Development of spontaneous uterine tumors in low molecular mass polypeptide-2 knockout mice","volume":"62","author":"Hayashi","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.046_bib17","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1038\/sj.onc.1209434","article-title":"The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2","volume":"25","author":"Hayashi","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2015.06.046_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ejca.2010.10.018","article-title":"Caveolin 1 is a marker of poor differentiation in Rhabdomyosarcoma","volume":"47","author":"Rossi","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.046_bib19","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.4161\/cc.24497","article-title":"Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide","volume":"12","author":"Quann","year":"2013","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.bbrc.2015.06.046_bib20","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.4161\/cc.10.24.18551","article-title":"Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival","volume":"10","author":"Wu","year":"2011","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.bbrc.2015.06.046_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2015.06.046_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yexmp.2007.08.004","article-title":"Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation","volume":"84","author":"Yang","year":"2008","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbrc.2015.06.046_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cell.2011.05.040","article-title":"Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis","volume":"146","author":"Goetz","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2015.06.046_bib24","doi-asserted-by":"crossref","first-page":"e84618","DOI":"10.1371\/journal.pone.0084618","article-title":"Phosphocaveolin-1 Enforces Tumor Growth and Chemoresistance in Rhabdomyosarcoma","volume":"9","author":"Faggi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2015.06.046_bib25","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2353\/ajpath.2009.080873","article-title":"An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers","volume":"174","author":"Witkiewicz","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2015.06.046_bib26","doi-asserted-by":"crossref","first-page":"11375","DOI":"10.1073\/pnas.172360799","article-title":"Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice","volume":"99","author":"Zhao","year":"2002","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.bbrc.2015.06.046_bib27","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1172\/JCI33338","article-title":"Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration","volume":"119","author":"Zhao","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2015.06.046_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/07853890410018899","article-title":"The Caveolin genes: from cell biology to medicine","volume":"36","author":"Williams","year":"2004","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbrc.2015.06.046_bib29","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.febslet.2012.05.029","article-title":"Potential role of LMP2 as an anti- oncogenic factor in human uterine leiomyosarcoma: morphological significance of calponin h1","volume":"586","author":"Hayashi","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2015.06.046_bib30","first-page":"839","article-title":"Reduced expression of Calponin h1 in Leiomyosarcoma of the Uterus","volume":"78","author":"Horiuchi","year":"1998","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2015.06.046_bib31","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jnci\/91.9.790","article-title":"Possible Role of Calponin h1 as a Tumor suppressor in human uterine leiomyosarcoma","volume":"91","author":"Horiuchi","year":"1999","journal-title":"J.\u00a0Nat. Can. Inst."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15301017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15301017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T22:44:05Z","timestamp":1655333045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15301017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0006291X15301017"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.046","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of CAVEOLIN 1 in uterine mesenchymal tumors: No relationship between malignancy and CAVEOLIN 1 expression","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}